Allarity Therapeutics (ALLR) Other Operating Expenses (2020 - 2024)
Allarity Therapeutics' (ALLR) quarterly Other Operating Expenses came in at $9.7 million in Q3 2024, up 1741.79% YoY from $526823.4 in Q4 2023, and up 1741.79% on a QoQ basis from -$591000.0 in Q3 2023.
Allarity Therapeutics (ALLR) Other Operating Expenses (2020 - 2024) Analysis & Trends
Allarity Therapeutics (ALLR) has 5 years of Other Operating Expenses data on file, last reported at $9.7 million in Q3 2024.
- Quarterly Other Operating Expenses rose 1741.79% year-over-year to $9.7 million in Q3 2024, while the trailing twelve-month figure through Jun 2025 was $9.7 million (up 1741.79% YoY) and the FY2024 annual result came in at $9.7 million, changed N/A from the prior year.
- Other Operating Expenses grew to $9.7 million in Q3 2024, from -$591000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $14.2 million in Q1 2022 to a low of -$2.1 million in Q4 2022.
- A 5-year average of $2.5 million and a median of $1.1 million in 2021 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2022 — Other Operating Expenses tumbled 412.76% — and 2024, when it soared 1741.79%.
- Tracing ALLR's Other Operating Expenses over 5 years: stood at $290000.0 in 2020, then soared by 129.66% to $666000.0 in 2021, then plunged by 412.76% to -$2.1 million in 2022, then soared by 71.63% to -$591000.0 in 2023, then soared by 1741.79% to $9.7 million in 2024.
- The last three Other Operating Expenses figures came in at $9.7 million (Q3 2024), -$591000.0 (Q3 2023), and $1.4 million (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Allarity Therapeutics | 22.75 Mn | 22.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 9.70 Mn |
| Sep 30, 2023 | -591,000.00 |
| Mar 31, 2023 | 1.39 Mn |
| Dec 31, 2022 | -2.08 Mn |
| Sep 30, 2022 | -268,000.00 |
| Jun 30, 2022 | 1.62 Mn |
| Mar 31, 2022 | 14.23 Mn |
| Dec 31, 2021 | 666,000.00 |
| Sep 30, 2021 | 2.66 Mn |
| Jun 30, 2021 | 1.85 Mn |
| Mar 31, 2021 | 889,000.00 |
| Sep 30, 2020 | 290,000.00 |